• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • PROs
    • Menopause Rating Scale
      • Menopause Rating Scale (MRS) – Languages
    • Aging Male Symptoms Scale
      • AMS – properties as an outcome measure
      • AMS – properties as a screening tool
    • Quality of Sexual Function Scale
      • Quality of Sexual Function Scale
    • Short Term Hormone Effect Scale
      • Short Term Hormone Effect Scale
    • Research team
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Tanja Boehnke

  • share 
  • share 
  • share 
  • share 

Publications

Eggebrecht Lisa, Bauerfeind Anja, Boehnke Tanja, Rizzo Manuel, Hagemann Christine, Lange Jens A., Viet Mareike, Pauls Karl, von Stockum Sophia, Klinghardt Moritz, Heinemann Klaas, Population characteristics of intrauterine device users in real-world clinical practice across Europe – insights from the EURAS-LCS12 study Contraception and Reproductive Medicine. 2025; 10.1186/s40834-025-00353-8.
Eggebrecht Lisa, Rizzo Manuel, Klinghardt Moritz, Boehnke Tanja, Barnett Clare, Heinemann Klaas, Real-world use of antispasmodic drugs during IUD insertion – insights from the large observational study EURAS-LCS12 Contraception & Reproductive Health Care . 2025; 10.1080/13625187.2025.2480086.
Bauerfeind Anja, von Stockum Sophia, Boehnke Tanja, Heinemann Klaas, Venous Thromboembolic Risk of Estradiol Valerate–Dienogest Compared with Ethinyl Estradiol–Levonorgestrel Combined Oral Contraceptives. Obstetrics & Gynecology. 2024; 10.1097/AOG.0000000000005509.
Boehnke Tanja, Bauerfeind Anja, Eggebrecht Lisa, Cellier Camille, Lange Jens A., Heinemann Klaas, Madden Tessa, Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS12 Contraception. 2024; https://doi.org/10.1016/j.contraception.2024.110444.
Boehnke Tanja, Franke Christian, Bauerfeind Anja, Heinemann Klaas, Kolberg-Liedtke Cornelia, Koelkebeck Katja, Impact of progestin type on the risk of drug interactions between combined oral contraceptives and psychotropic drugs: A pooled analysis of real-world data Contraception. 2024; 10.1016/j.contraception.2024.110786.
Boehnke Tanja, Eggebrecht Lisa, Viet Mareike, Heinemann Klaas, Bauerfeind Anja, How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users? Contraception. 2023; 10.1016/j.contraception.2023.110003.
Boehnke Tanja, Bauerfeind Anja, Hagemann Christine, Lange Jens A., Heinemann Klaas, Intrauterine device prescribing patterns and types in Europe – a cross-sectional analysis of the European Active Surveillance LCS12 Study. European Gynecology & Obstetrics. 2022; 29–40. 10.53260/EGO.224015 .
Download PDF: Boehnke-et-al.-2022_IUD-prescribing-patterns-and-types-in-Europe_LCS12.pdf

sidebar

Executive Team

  • Clare Barnett
  • Karl Pauls
  • Michael Schultze
  • Alfred Pauls
  • Do Minh Thai
  • Elisabeth Finger
  • Jens A. Lange
  • Antje Simon

Management Board

  • Klaas Heinemann
  • Clare Barnett
  • Marc Pignot
  • Karl Pauls
  • Johanna Poppe

Project Management Team

  • Pauline De Corte
  • Lisa Eggebrecht
  • Mohammed Dagher
  • Ulrike Amann-Gassner
  • Armin Papkalla
  • Silke Zimmermann
  • Nik Kolb

Search

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Patient Reported Outcomes (PROs)
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2025 ZEG Berlin

Impressum

Website by Laura Yeffeth.